Business Context and Reporting Period
MiMedx Group, Inc. filed this Form 8-K on July 31, 2013, to announce its financial results for the second quarter of 2013. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document states that the detailed financial results are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the text of this 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors are directed to the referenced press release for comparative analysis.
Guidance, Outlook, and Management Commentary
Management announced that company executives would discuss the second-quarter results with investors via a conference call. Access information, date, and time for the call were provided on the company's website (www.mimedx.com). The filing explicitly states that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Important Facts for Investor Verification
- Verify the specific financial figures (revenue, net income, EPS) in the press release attached as Exhibit 99.1, as they are absent from the 8-K text.
- Confirm the date and time of the investor conference call via the company website.
- Note the legal disclaimer that the financial information in this filing is "furnished" rather than "filed," limiting liability under Section 18 of the Exchange Act.
- Review the full press release for any guidance, risk factors, or unusual items not summarized in this current report.